09Mar 2024
High Apolipoprotein A-IV Levels Linked to Lower Cancer Risk in CKD Patients

High Apolipoprotein A-IV Levels Linked to Lower Cancer Risk in CKD Patients

High serum apolipoprotein A-IV (apoA-IV) levels were investigated for association with cancer in a study. Analyzing 5039 patients over 6.5 years, those with apoA-IV concentrations above the median exhibited lower odds of prior cancer history (OR = 0.79, p = 0.02). Additionally, higher apoA-IV levels correlated with reduced risk of incident cancer (HR = 0.72, 95%CI 0.57–0.90, P = 0.004) and fatal cancer events (HR = 0.62, 95%CI 0.44–0.88, P = 0.007). These findings suggest a potential protective role of elevated apoA-IV against cancer development and mortality in CKD patients.

  • #nephrology

Like

Save

Share